Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens

Author:

Bell Katy J.L.1,Hayen Andrew1,Macaskill Petra1,Craig Jonathan C.1,Neal Bruce C.1,Fox Kim M.1,Remme Willem J.1,Asselbergs Folkert W.1,van Gilst Wiek H.1,MacMahon Stephen1,Remuzzi Giuseppe1,Ruggenenti Piero1,Teo Koon K.1,Irwig Les1

Affiliation:

1. From the Screening and Test Evaluation Program (K.J.L.B., A.H., P.M., J.C.C., L.I.), School of Public Health, University of Sydney, Sydney, New South Wales, Australia; Department of Nephrology (J.C.C.), Children’s Hospital at Westmead, Westmead, New South Wales, Australia; George Institute for International Research (B.C.N., S.M.), Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia; Cardiology Department (K.M.F.), Royal Brompton Hospital, London, United Kingdom;...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3